Investigational Drug Information for Idalopirdine
✉ Email this page to a colleague
What is the development status for investigational drug Idalopirdine?
Idalopirdine is an investigational drug.
There have been 10 clinical trials for Idalopirdine.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2013.
The most common disease conditions in clinical trials are Alzheimer Disease and [disabled in preview]. The leading clinical trial sponsors are H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., and [disabled in preview].
Summary for Idalopirdine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 56 |
| WIPO Patent Applications | 37 |
| Japanese Patent Applications | 13 |
| Clinical Trial Progress | Phase 3 (2013-10-01) |
| Vendors | 54 |
Recent Clinical Trials for Idalopirdine
| Title | Sponsor | Phase |
|---|---|---|
| Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease | H. Lundbeck A/S | Phase 1 |
| Bioequivalence Study of Idalopirdine in Healthy Subjects | H. Lundbeck A/S | Phase 1 |
| Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men | H. Lundbeck A/S | Phase 1 |
Clinical Trial Summary for Idalopirdine
Top disease conditions for Idalopirdine
Top clinical trial sponsors for Idalopirdine
US Patents for Idalopirdine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
